Latest filing published 12 Feb 2024 for ImmunoGen, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Renee Lentini appears in our data through filings on ImmunoGen, Inc. shares, published by SEC (Form 4). In total, 12 filings cover trades dated from 30 June 2021 to 12 February 2024.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The record was last updated on 12 February 2024 with a transaction in ImmunoGen, Inc. Typically, a trade is published a median of 4 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations